Mark J. Rosenblum
2019 - Flex Pharma
In 2019, Mark J. Rosenblum earned a total compensation of $438.3K as Executive Vice President, Finance and Chief Financial Officer at Flex Pharma.
Compensation breakdown
| Bonus | $19,300 |
|---|---|
| Option Awards | $122,119 |
| Salary | $81,708 |
| Other | $215,160 |
| Total | $438,287 |
Rosenblum received $215.2K in other compensation, accounting for 49% of the total pay in 2019.
Rosenblum also received $19.3K in bonus, $122.1K in option awards and $81.7K in salary.
Rankings
In 2019, Mark J. Rosenblum's compensation ranked 12,115th out of 13,971 executives tracked by ExecPay. In other words, Rosenblum earned more than 13.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,115 out of 13,971 | 13th |
Division Manufacturing | 4,909 out of 5,701 | 14th |
Major group Chemicals And Allied Products | 1,936 out of 2,200 | 12th |
Industry group Drugs | 1,669 out of 1,886 | 12th |
Industry Pharmaceutical Preparations | 1,237 out of 1,398 | 12th |
Source: SEC filing on April 27, 2021.
Rosenblum's colleagues
We found one more compensation record of an executive who worked with Mark J. Rosenblum at Flex Pharma in 2019.
2019
David Arthur
Flex Pharma